Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.25    -0.005 (-1.89%)
Bid:
0.24
Ask:
0.26
Spread: 0.02 (8.333%)
Market Cap: £15.07m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading Update

16 Apr 2019 07:00

RNS Number : 2660W
CAP-XX Limited
16 April 2019
 

16 April 2019

 

CAP-XX Limited

("CAP-XX" or the "Company")

Trading Update

CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, today announces a trading update in respect of its recent activities.

 

CAP-XX to open European office

 

Over the last few quarters, CAP-XX has achieved success in securing orders for the supply of supercapacitors to Tier-1 component suppliers to the global automotive industry. In order to strengthen its relationships in this increasingly important segment, the Company has appointed Marco Ranalli to lead CAP-XX's European business strategy serving the specialist demands of the automotive industry as well as the internet of things (IoT). Mr Ranalli was most recently Global Director of Gentherm's Battery Systems Business Unit and has over 20 years' experience in the automotive markets. Gentherm is a NASDAQ listed automotive supply company. Mr Ranalli will also evaluate the potential benefits of establishing a local engineering and new business centre in Germany and in the meantime will work alongside CAP-XX's European distributor network to develop supercapacitor solutions to meet the specific demands of the automotive sector.

 

Pipeline and licensing activity

 

CAP-XX is continuing to receive record interest in its expanded range of supercapacitors, notably for applications relating to the IoT. The range of markets where enquiries are at record levels include Automotive (non power train). Enquiries are also at a high level for customers in the IoT (Wireless, Track & Trace applications), and Smart Meter industries. There has been some softening in demand from manufacturers of Wearable Technologies. It is clear that the slowdown in vehicle demand has not affected demand for the Company's products in the informatics and other low energy automotive applications, although the time to market for developing large cells for vehicle motive power and storage applications has slowed, with the result that CAP-XX has rebalanced its immediate-term focus around small cell automotive applications. The Company's previously announced sales to Spire have not been followed up with new orders, as Spire has been impacted by trade tariffs into the US. Spire has repositioned its device from the sports leisure market to the professional medical market in order to sustain a higher price point.

 

CAP-XX's current licensees include Murata, AVX and TDK. The Company remains in active discussions with a small group of potential further licensees in addition to a similar number of discussions which are at a less advanced stage. Most of these potential licensees are international component makers and companies focused on the energy storage markets. It is not possible to be precise on the timing of securing additional licensees, although the Board believes that further progress will be made during this calendar year. In the meantime, CAP-XX continues to enjoy rising enquiry levels and views future licensing opportunities with increasing confidence.

 

Intellectual property

 

CAP-XX continues to vigorously defend its intellectual property (IP) which it believes to be the cornerstone of its position as the world leader in prismatic supercapacitors, as well as a world leader in the broader supercapacitor market. The level of IP infringement it suffers as a consequence of this has prompted the Company to dedicate the necessary resources to protect its position through litigation where necessary. The level and strength of CAP-XX's international licensees bears testament to this position and IP conflict resolution is an active source of new licensees whilst defence of the IP is a part of the Company's duty of care to its contracted licensees. The Company is currently in the process of litigation with two counterparties in the United States. The Board is aware that the litigation process in the US can be protracted. CAP-XX continues to provide for and monitor its costs in this area very closely and continually evaluates the benefits of its IP defence strategy as well as constantly reviewing the requirement to file additional patent infringement claims.

 

Outlook

 

In the Company's announcement of 6 March 2019, CAP-XX highlighted the importance of a series of customer visits in relation to understanding certain customers' order positions and how these will translate into shorter term sales revenue. The Company is still in the process of conducting a number of these customer visits and the Board will provide an update on trading in respect of the anticipated overall outcome for the full year ending 30 June 2019 in due course.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGUPGCUPBGMA
Date   Source Headline
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSSubscription to raise £1.75 million
23rd Oct 20187:00 amRNSExercise of share options & PDMR shareholding
22nd Oct 201810:09 amRNSNotice of AGM
17th Oct 20187:00 amRNSAudited results for the year ended 30 June 2018
8th Oct 20182:05 pmRNSSecond Price Monitoring Extn
8th Oct 20182:00 pmRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSNew licence agreement with TDK
5th Oct 20188:00 amRNSNotice of Results
25th Sep 201810:22 amRNSSpire Health Tags launched in Apple stores
18th Jul 20188:30 amRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSExercise of share options
22nd Jun 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
21st Jun 20187:00 amRNSExercise of share options & PDMR shareholding
20th Jun 20187:00 amRNSTrading update
1st May 20187:00 amRNSExercise of employee share options
11th Apr 20187:00 amRNSDeveloping first 3V thin prismatic supercapacitors
6th Mar 20182:25 pmRNSInterim Results (Replacement)
6th Mar 20187:00 amRNSInterim Results
15th Feb 20188:46 amRNSNotice of results
16th Jan 20187:00 amRNSHolding(s) in Company
18th Dec 201711:42 amRNSGrant of Share Options
12th Dec 201710:35 amRNSIssue of Shares and Director/PDMR Shareholdings
23rd Nov 20179:40 amRNSResult of AGM and Chairman's AGM statement
20th Nov 20177:00 amRNSSpire launches Thinline enabled wearable
30th Oct 20177:00 amRNSNotice of AGM
9th Oct 20177:00 amRNSAudited results for the year ended 30 June 2017
22nd Sep 20178:59 amRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of Results
23rd Aug 20178:37 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSFirst high-volume order for Thinline
29th Jun 20178:22 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20177:00 amRNSTrading update for year ending 30 June 2017
25th May 20178:51 amRNSExtension of option term and Director/PDMR dealing
19th Apr 20178:47 amRNSHolding(s) in Company
20th Mar 20177:00 amRNSInterim Results
9th Mar 20177:00 amRNSCAP-XX launches new cylindrical supercapacitors
1st Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.